Cargando…
Human soluble CD39 displays substrate inhibition in a substrate-specific manner
CD39 (ectonucleoside triphosphate diphosphohydrolase-1; ENTPD1) metabolizes extracellular ATP and ADP to AMP. AMP is subsequently metabolized by CD79 to adenosine. CD39 activity is therefore a key regulator of purinergic signalling in cancer, thrombosis, and autoimmune diseases. In this study we dem...
Autores principales: | Vadlamani, Venkat M. K., Gunasinghe, Kavinda K. J., Chee, Xavier W., Rahman, Taufiq, Harper, Matthew T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238538/ https://www.ncbi.nlm.nih.gov/pubmed/37268726 http://dx.doi.org/10.1038/s41598-023-36257-3 |
Ejemplares similares
-
Probing ADAMTS13 Substrate Specificity using Phage Display
por: Desch, Karl C., et al.
Publicado: (2015) -
J1/tenascin in substrate-bound and soluble form displays contrary effects on neurite outgrowth
Publicado: (1991) -
Identification of Calpain Substrates by ORF Phage Display
por: Caberoy, Nora B., et al.
Publicado: (2011) -
Substrate stiffness regulates solubility of cellular vimentin
por: Murray, Maria E., et al.
Publicado: (2014) -
Monitoring and characterizing soluble and membrane-bound ectonucleotidases CD73 and CD39
por: Goueli, Said A., et al.
Publicado: (2019)